Extendicare Announces 2026 Second Quarter Results #Chemicals #Pharmaceutical #HealthCare #Medical #Pharmaceuticals #Earnings #QuarterlyResults #Results #TSX #Investing
Markham, Ontario--(Newsfile Corp. - August 6, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") today reported results for the three and six months ended June 30, 2026. Second Quarter 2026 HighlightsAdjusted EBITDA(1) increased by $28.5 million or 71.7% from Q2 2025 to $68.3 million, driven primarily by contributions from the acquisitions of CBI Home Health and Closing the Gap, as well as continued organic growth in home health care service volumes and SGP clients served.Home... http://dlvr.it/TTv4Fz